206 related articles for article (PubMed ID: 32961824)
1. Adenosine Receptor Ligands: Coumarin-Chalcone Hybrids as Modulating Agents on the Activity of
Vazquez-Rodriguez S; Vilar S; Kachler S; Klotz KN; Uriarte E; Borges F; Matos MJ
Molecules; 2020 Sep; 25(18):. PubMed ID: 32961824
[TBL] [Abstract][Full Text] [Related]
2. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
[TBL] [Abstract][Full Text] [Related]
3. Development of novel pyridazinone-based adenosine receptor ligands.
Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Pasquini S; Dal Ben D; Colotta V
Bioorg Med Chem Lett; 2018 May; 28(9):1484-1489. PubMed ID: 29627261
[TBL] [Abstract][Full Text] [Related]
4. Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold.
Matos MJ; Vilar S; Kachler S; Celeiro M; Vazquez-Rodriguez S; Santana L; Uriarte E; Hripcsak G; Borges F; Klotz KN
Bioorg Chem; 2015 Aug; 61():1-6. PubMed ID: 26042529
[TBL] [Abstract][Full Text] [Related]
5. 7-Amino-2-aryl/hetero-aryl-5-oxo-5,8-dihydro[1,2,4]triazolo[1,5-a]pyridine-6-carbonitriles: Synthesis and adenosine receptor binding studies.
Shaik K; Deb PK; Mailavaram RP; Chandrasekaran B; Kachler S; Klotz KN; Jaber AMY
Chem Biol Drug Des; 2019 Aug; 94(2):1568-1573. PubMed ID: 30985956
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Biological Evaluation of 1,3,5-Triazine Derivatives Targeting hA
Park S; Ahn Y; Kim Y; Roh EJ; Lee Y; Han C; Yoo HM; Yu J
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807265
[TBL] [Abstract][Full Text] [Related]
7. Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study.
Federico S; Ciancetta A; Porta N; Redenti S; Pastorin G; Cacciari B; Klotz KN; Moro S; Spalluto G
J Med Chem; 2014 Jul; 57(14):6210-25. PubMed ID: 24972108
[TBL] [Abstract][Full Text] [Related]
8. Chalcone-inspired rA
Matthee C; Terre'Blanche G; Janse van Rensburg HD; Aucamp J; Legoabe LJ
Chem Biol Drug Des; 2022 Mar; 99(3):416-437. PubMed ID: 34878728
[TBL] [Abstract][Full Text] [Related]
9. Coumarins and adenosine receptors: New perceptions in structure-affinity relationships.
Fonseca A; Matos MJ; Vilar S; Kachler S; Klotz KN; Uriarte E; Borges F
Chem Biol Drug Des; 2018 Jan; 91(1):245-256. PubMed ID: 28734062
[TBL] [Abstract][Full Text] [Related]
10. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
[TBL] [Abstract][Full Text] [Related]
11. Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors.
Squarcialupi L; Falsini M; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Volpini R; Colotta V
Bioorg Med Chem; 2016 Jun; 24(12):2794-808. PubMed ID: 27161878
[TBL] [Abstract][Full Text] [Related]
12. Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A
Poli D; Falsini M; Varano F; Betti M; Varani K; Vincenzi F; Pugliese AM; Pedata F; Dal Ben D; Thomas A; Palchetti I; Bettazzi F; Catarzi D; Colotta V
Eur J Med Chem; 2017 Jan; 125():611-628. PubMed ID: 27721147
[TBL] [Abstract][Full Text] [Related]
13. Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A
Falsini M; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Volpini R; Di Cesare Mannelli L; Ghelardini C; Colotta V
Bioorg Chem; 2019 Jun; 87():380-394. PubMed ID: 30913470
[TBL] [Abstract][Full Text] [Related]
14. Insight into the interactions between novel coumarin derivatives and human A3 adenosine receptors.
Matos MJ; Vilar S; Kachler S; Fonseca A; Santana L; Uriarte E; Borges F; Tatonetti NP; Klotz KN
ChemMedChem; 2014 Oct; 9(10):2245-53. PubMed ID: 25044491
[TBL] [Abstract][Full Text] [Related]
15. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A
Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560
[TBL] [Abstract][Full Text] [Related]
16. A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.
Kuder KJ; Michalik I; Kieć-Kononowicz K; Kolb P
J Comput Aided Mol Des; 2020 Jun; 34(6):697-707. PubMed ID: 32112287
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, adenosine receptor binding and molecular modelling studies of novel thieno[2,3-d]pyrimidine derivatives.
Deb PK; Mailavaram R; Chandrasekaran B; Kaki VR; Kaur R; Kachler S; Klotz KN; Akkinepally RR
Chem Biol Drug Des; 2018 Apr; 91(4):962-969. PubMed ID: 29194979
[TBL] [Abstract][Full Text] [Related]
18. N-[9-(ortho-fluorobenzyl)-2-phenyl-8-azapurin-6-yl]-amides as potent and selective ligands for A₁ adenosine receptors.
Borghini A; Pietra D; Leonardi M; Giorgi I; Bianucci AM
Chem Biol Drug Des; 2013 Jul; 82(1):22-38. PubMed ID: 23480235
[TBL] [Abstract][Full Text] [Related]
19. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
[TBL] [Abstract][Full Text] [Related]
20. Substituted 4-phenylthiazoles: Development of potent and selective A
Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
